Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a recently emerged
pathogenic human coronavirus that belongs to the sarbecovirus lineage of the genus …

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus is continuously
evolving, and this poses a major threat to antibody therapies and currently authorized …

The potential for future coronavirus outbreaks highlights the need to broadly target this
group of pathogens. We used an epitope-agnostic approach to identify six monoclonal …

The rapid development of micromanipulation technologies has opened exciting new
opportunities for the actuation, selection and assembly of a variety of non-biological and …

The persistent COVID-19 pandemic since 2020 has brought an enormous public health
burden to the global society and is accompanied by various evolution of the virus genome …

A full understanding of the inactivated COVID-19 vaccine-mediated antibody responses to
SARS-CoV-2 circulating variants will inform vaccine effectiveness and vaccination …

Mutations in the spike glycoproteins of SARS-CoV-2 variants of concern have independently
been shown to enhance aspects of spike protein fitness. Here, we describe an antibody …

Responsible for more than 4.9 million deaths so far, COVID-19, caused by SARS-CoV-2, is
instigating devastating effects on the global health care system whose impacts could be …

Population antibody response is thought to be important in selection of virus variants. We
report that SARS-CoV-2 infection elicits a population immune response that is mediated by a …

Due to their small sizes, microrobots are advantageous for accessing hard-to-reach spaces
for delivery and measurement. However, their small sizes also bring challenges in on-board …